The phosphine ligand is available on the kilo scale for the first time, providing scientists with a powerful solution for cross-coupling chemistry
The products are based on a combination of mushrooms and cannabinoids that have achieved a strong therapeutic effect using low concentrations of THC. The treatment is expected to be launched in Israel, US and UK in H2 2022
Collaboration with MTPC to discover novel hit compounds for multiple drug targets
The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers
Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022
According to Fortune Business Insights, the launch of new PCR-based detection techniques will lead to a surge in demand for PCR instruments in the coming years
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
The tie-up combines Abbisko Therapeutics’ proprietary drug discovery platform with Lilly’s disease and discovery expertise
Market data indicates that more than twenty percent of the new chemical entities being developed use roller compaction technology in their development and commercialization
Simulated Moving Bed (SMB) technology is a highly engineered process for implementing chromatographic separation
Subscribe To Our Newsletter & Stay Updated
